CENTOGENE NV (CNTG)       0.7175  -0.08 (-9.74%)

0.7175  -0.08 (-9.74%)

NL0014040206 - Common Stock

News Image
4 days ago - Centogene NV

CENTOGENE to Participate in Upcoming Conferences in December

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for...

News Image
12 days ago - Seeking Alpha

CNTG stock spikes as H.C. Wainwright initiates Buy with over 200% upside (NASDAQ:CNTG)

Shares of German nano-cap life sciences company Centogene N.V. (CNTG) rallied in the morning hours Wednesday after H.C

News Image
14 days ago - Centogene NV

CENTOGENE Announces Changes to Supervisory Board, Including Appointment of Mary Sheahan

Adding significant financial expertise with an impressive track record in value creation

News Image
14 days ago - Centogene NV

CENTOGENE Announces Changes to Supervisory Board, Including Appointment of Mary Sheahan

Adding significant financial expertise with an impressive track record in value creation...

News Image
25 days ago - Centogene NV

CENTOGENE to Participate in Upcoming Conferences in November

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for...

News Image
a month ago - Centogene NV

CENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network

Company’s launch of Biodata Network offers new portfolio of data-driven solutionsCollaboration with BC Platforms increases access to data-driven genomic...

News Image
2 months ago - Centogene NV

CENTOGENE to Participate in Upcoming Partnering Conferences in October

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential...

News Image
3 months ago - Centogene NV

CENTOGENE to Present at Upcoming Investor & Partnering Conferences in September

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential...

News Image
5 months ago - Centogene NV

CENTOGENE Reports First Quarter 2022 Financial Results

On Track for FY 2022 Guidance Q1 2022 revenue rises 3% to €10.3 million Completed phase out of COVID-19 Business segment in Q1 2022Positioning Pharma and...

News Image
5 months ago - Centogene NV

CENTOGENE Announces Shareholder Approval of All Resolutions at 2022 Annual General Meeting

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 27, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage, essential...

News Image
5 months ago - Centogene NV

CENTOGENE Announces Appointment of Miguel Coego Rios as Chief Financial Officer

Interim CFO Miguel Coego Rios appointed as Managing Director and permanent CFO...

News Image
6 months ago - Centogene NV

CENTOGENE and Agios Expand Partnership for Clinical Development of PYRUKYND® (mitapivat) to Treat Children With Rare Blood Disease

Working together on the world’s first treatment that targets the underlying causes of pyruvate kinase (“PK”) deficiency in children under the age of 18...

News Image
6 months ago - Centogene NV

CENTOGENE’s CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platforms Compliant With European IVD Regulatory Framework

CE-marked clinical decision support platform enables laboratories to provide best-in-class diagnostics of genetic diseases...